Literature DB >> 23689154

Immunoglobulin M nephropathy in adults: a clinicopathological study.

Muhammed Mubarak1, Rubina Naqvi, Javed Kazi, Shaheera Shakeel.   

Abstract

INTRODUCTION: There is no data specifically on the clinical and immunopathologic features of Immunoglobulin M nephropathy (IgMN) in adults with kidney diseases in Pakistan.
MATERIALS AND METHODS: We retrospectively reviewed our adult native renal biopsy records from May 2001 to April 2010 and identified 57 cases out of a total of 1,753 records labeled as IgMN on final histopathological analysis. Among these, 41 cases were included in the present analysis. Their relevant data items were collected from the case files and biopsy reports.
RESULTS: The mean age of this cohort was 30.21 ± 10.12 years. The male-female ratio was 1.15:1. The most common presentation was idiopathic nephrotic syndrome. Hematuria and hypertension at presentation were noted in 24 (58.5%) and 10 (24.4%) patients, respectively. The most common morphologic change was glomerular mesangial cell proliferation, found in 28 biopsies (68.3%). Mesangial matrix expansion was noted in 16 (39%). Minor glomerular alterations were noted in 5 cases (12.2%) and focal segmental glomerulosclerosis in 4 (9.8%). Immunofluorescence microscopy showed diffuse mesangial positivity of IgM in all specimens. Subdominant IgA was noted in 6 cases (14.6%). Complements C3 and C1q were found in 28 (68.3%) and 21 (51.2%) patients, respectively.
CONCLUSIONS: Our results show that IgMN is not very common in adults. Its clinicopathological spectrum is similar to that described from the neighboring countries, showing a spectrum of morphologic changes ranging from minor changes to focal segmental glomerulosclerosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23689154

Source DB:  PubMed          Journal:  Iran J Kidney Dis        ISSN: 1735-8582            Impact factor:   0.892


  7 in total

1.  Comment on: IgM nephropathy: Can we still ignore it.

Authors:  Muhammed Mubarak
Journal:  J Nephropathol       Date:  2013-10-01

2.  IgM nephropathy; time to act.

Authors:  Muhammed Mubarak
Journal:  J Nephropathol       Date:  2014-01-01

Review 3.  IgM nephropathy: is it closer to minimal change disease or to focal segmental glomerulosclerosis?

Authors:  R Brugnano; R Del Sordo; C Covarelli; E Gnappi; S Pasquali
Journal:  J Nephrol       Date:  2016-02-03       Impact factor: 3.902

4.  IgM nephropathy: timely response to a call for action.

Authors:  Muhammed Mubarak; Hamid Nasri
Journal:  J Renal Inj Prev       Date:  2013-11-02

5.  Coexistence of Fabry disease with IgM nephropathy: A case report.

Authors:  Huizhen Wu; Tapas Ranjan Behera; Jianguang Gong; Quanquan Shen
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

6.  IgM mesangial deposition as a risk factor for relapses of adult-onset minimal change disease.

Authors:  Cheng-Wen Yang; Fan-Yu Chen; Fu-Pang Chang; Yang Ho; Bo-Sheng Wu; An-Hang Yang; Der-Cherng Tarng; Chih-Yu Yang
Journal:  BMC Nephrol       Date:  2021-01-12       Impact factor: 2.388

7.  Development of Immunoglobulin M Nephropathy in a Pregnant Woman.

Authors:  Koray Uludag; Yesim Celik; Nuray Yildirimer; Fatos Tekelioglu; Ali Ihsan Gunal
Journal:  Cureus       Date:  2021-12-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.